Cypress Capital Group Raises Holdings in Solventum Co. (NYSE:SOLV)

Cypress Capital Group lifted its stake in Solventum Co. (NYSE:SOLV) by 9.1% during the third quarter, Holdings Channel reports. The institutional investor owned 20,706 shares of the company’s stock after acquiring an additional 1,719 shares during the quarter. Cypress Capital Group’s holdings in Solventum were worth $1,444,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. Deseret Mutual Benefit Administrators acquired a new position in shares of Solventum in the 2nd quarter valued at $25,000. Hollencrest Capital Management purchased a new stake in shares of Solventum in the second quarter valued at approximately $25,000. Partnership Wealth Management LLC acquired a new position in shares of Solventum during the 2nd quarter worth approximately $26,000. Richard W. Paul & Associates LLC purchased a new position in shares of Solventum during the 2nd quarter valued at approximately $26,000. Finally, Family Firm Inc. acquired a new position in Solventum during the second quarter worth $26,000.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on SOLV shares. Piper Sandler raised their price target on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Stifel Nicolaus assumed coverage on Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price on the stock. Wells Fargo & Company dropped their price target on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research report on Friday, August 9th. Wolfe Research assumed coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating on the stock. Finally, BTIG Research started coverage on shares of Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating for the company. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Solventum currently has an average rating of “Hold” and a consensus price target of $68.00.

Solventum Trading Up 2.0 %

Solventum stock opened at $68.39 on Thursday. The business has a fifty day moving average of $70.49 and a two-hundred day moving average of $62.26. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.